Ampio Pharma (AMPE) Shares Slammed as Ampion Phase 3 Misses Endpoint

June 30, 2016 8:50 AM EDT Send to a Friend

Ampio Pharma (NYSE: AMPE) shares are trading lower early ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ampio Pharma (AMPE) Shares Slammed as Ampion Phase 3 Misses Endpoint

Member Login

Free News Feed